Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Schizophrenia Research
|
September 1, 1995
Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET
N S Gray, L S Pilowsky, J A Gray, et al.
Psychopharmacology
|
January 1, 1992
Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man
N S Gray, A D Pickering, D R Hemsley, et al.
The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology
|
September 8, 2001
Context dependent latent inhibition in adult humans
N S Gray, J Williams, M Fernandez, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 1, 1997
Kamin blocking is not disrupted by amphetamine in human subjects
N S Gray, A D Pickering, J A Gray, et al.
Oncogene
|
August 8, 2012
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
Q Yang, L Liao, X Deng, et al.
Journal of Psychiatric Research
|
April 30, 1999
Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication
B Franz, D J Buysse, C R Cherry, et al.
Journal of Biological Regulators and Homeostatic Agents
|
February 28, 2019
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors
, I Tusa, G Cheloni, et al.
Oncogene
|
December 1, 2015
ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT
D N Debruyne, N Bhatnagar, B Sharma, et al.
Oncogene
|
June 10, 2014
Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells
J Wang, O Mikse, R G Liao, et al.
Diabetologia
|
March 12, 2013
Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets
R Jain, D Jain, Q Liu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Schizophrenia Research
|
September 1, 1995
Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET
N S Gray, L S Pilowsky, J A Gray, et al.
Psychopharmacology
|
January 1, 1992
Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man
N S Gray, A D Pickering, D R Hemsley, et al.
The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology
|
September 8, 2001
Context dependent latent inhibition in adult humans
N S Gray, J Williams, M Fernandez, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 1, 1997
Kamin blocking is not disrupted by amphetamine in human subjects
N S Gray, A D Pickering, J A Gray, et al.
Oncogene
|
August 8, 2012
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
Q Yang, L Liao, X Deng, et al.
Journal of Psychiatric Research
|
April 30, 1999
Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication
B Franz, D J Buysse, C R Cherry, et al.
Journal of Biological Regulators and Homeostatic Agents
|
February 28, 2019
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors
, I Tusa, G Cheloni, et al.
Oncogene
|
December 1, 2015
ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT
D N Debruyne, N Bhatnagar, B Sharma, et al.
Oncogene
|
June 10, 2014
Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells
J Wang, O Mikse, R G Liao, et al.
Diabetologia
|
March 12, 2013
Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets
R Jain, D Jain, Q Liu, et al.
Page
of 4